Drugs / DNP007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06400771 | Jun → Dec 2024 | metabolic dysfunction-associated steatohepatitis, transplant rejection | Seoul National University Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DNP007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06400771 ↗ |
| Modality | Monoclonal antibody | “an anti-ICAM-1 mouse monoclonal minority” NCT06400771 ↗ |
| Route | Intravenous | “receive intravenous administration of the clinical trial drug for 30 minutes” NCT06400771 ↗ |
| Target | ICAM1 | “an anti-ICAM-1 mouse monoclonal minority” NCT06400771 ↗ |